Hostname: page-component-8448b6f56d-t5pn6 Total loading time: 0 Render date: 2024-04-24T12:24:48.885Z Has data issue: false hasContentIssue false
  • English
  • Français

A Comparative Trial of Desipramine and Nortriptyline in Depression

Published online by Cambridge University Press:  29 January 2018

J. A. Stewart  and
P. H. Mitchell
J. A. Stewart
Affiliation:
St. Augustine's Hospital, Chartham, Canterbury, Kent. (Now Consultant Psychiatrist, Hellingly Hospital, Hailsham, Sussex)
P. H. Mitchell
Affiliation:
St. Augustine's Hospital, Chartham, Canterbury, Kent
Get access Rights & Permissions [Opens in a new window]

Extract

Seven drugs of the imino-dibenzyl group are now generally available in Great Britain (imipramine, amitriptyline, desipramine, nortriptyline, protriptyline, trimipramine and opipramol). All are similar in their actions and side-effects. Imipramine, the first to appear, has been shown to be more effective than placebo in the treatment of depression, though with much better results in men than in women (M.R.C. Clinical Trial, 1965). Desipramine, a metabolite of impramine, was introduced with the claim that its action was quicker than that of imipramine, though this has never been clearly demonstrated. Trials of desipramine against imipramine (Waldron and Bates, 1965; Rose and Westhead, 1964) showed no significant difference between these drugs. Comparison of amitriptyline and imipramine (Burt, Gordon, Holt and Hordern, 1962), showed amitriptyline to be at least as effective as imipramine and significantly superior in the treatment of endogenous depression. Comparisons of nortriptyline and amitriptyline (Forrest, Affleck, Gibb and Priest, 1964; Rose, Leahy, Martin and Westhead, 1965) showed no significant difference between these drugs.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 114 , Issue 509 , April 1968 , pp. 469 - 471
Copyright
Copyright © Royal College of Psychiatrists, 1968 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Burt, C. G., Gordon, W. F., Holt, N. F., and Hordern, A. (1962). “Amitriptyline in depressive states” J. ment. Sci., 108, 711–730.Google Scholar
Forrest, E. D., Affleck, J. W., Gibb, I. A., and Priest, R. G. (1964). “Comparative trial of nortriptyline and amitriptyline” Scot. med. J., 9, 341–345.Google Scholar
Hamilton, M. (1960). “A rating scale for depression” J. Neurol. Neurosurg. Psychiat., 23, 56–62.CrossRefGoogle Scholar
Medical Research Council (1965). “Clinical trial of the treatment of depressive illnesses” Brit. med. J., i, 881–886.Google Scholar
Rose, J. T., and Westhead, T. T. (1964). “Comparison of desipramine and imipramine in depression” Amer. J. Psychiat., 121, 496–498.Google Scholar
Rose, J. T., Leahy, M. R., Martin, I. C. A., and Westhead, T. T. (1965). “A comparison of nortriptyline and amitriptyline in depression” Brit. J. Psychiat., 111, 1101–1103.Google Scholar
Waldron, J., and Bates, T. J. N. (1965). “The management of depression in hospital. A comparative trial of desipramine and imipramine” Ibid., 111, 511–516.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.